Institutional investors purchased a net $2.0 million shares of ATHX during the quarter ended June 2017 and now own 19.64% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RBC CAPITAL MARKETS LLC (INVESTM... Bought 380.0 Thousand shares of Athersys Inc
BLACKROCK FUND ADVISORS Bought 367.6 Thousand shares of Athersys Inc
THE VANGUARD GROUP, INC. Bought 366.6 Thousand shares of Athersys Inc